These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 31662509)
1. Central Injection of Leptin Increases Sympathetic Nerve Outflows to the Stomach and Spleen in Anesthetized Rats. Tanida M; Iwasaki Y; Yamamoto N In Vivo; 2019; 33(6):1827-1832. PubMed ID: 31662509 [TBL] [Abstract][Full Text] [Related]
2. Central AMP-activated protein kinase affects sympathetic nerve activity in rats. Tanida M; Yamamoto N Neurosci Lett; 2011 Oct; 503(3):167-70. PubMed ID: 21893163 [TBL] [Abstract][Full Text] [Related]
3. Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation. Tanida M; Yamamoto N; Shibamoto T; Rahmouni K PLoS One; 2013; 8(2):e56660. PubMed ID: 23418591 [TBL] [Abstract][Full Text] [Related]
5. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Yu X; McCorkle S; Wang M; Lee Y; Li J; Saha AK; Unger RH; Ruderman NB Diabetologia; 2004 Nov; 47(11):2012-21. PubMed ID: 15578153 [TBL] [Abstract][Full Text] [Related]
6. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Mountjoy PD; Bailey SJ; Rutter GA Diabetologia; 2007 Jan; 50(1):168-77. PubMed ID: 17093945 [TBL] [Abstract][Full Text] [Related]
7. 5-Aminoimidazole-4-carboxamide ribonucleotide prevents fat gain following the cessation of voluntary physical activity. Ruegsegger GN; Sevage JA; Childs TE; Grigsby KB; Booth FW Exp Physiol; 2017 Nov; 102(11):1474-1485. PubMed ID: 28786140 [TBL] [Abstract][Full Text] [Related]
8. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase. Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340 [TBL] [Abstract][Full Text] [Related]
10. Leptin receptor signaling in the hypothalamus regulates hepatic autonomic nerve activity via phosphatidylinositol 3-kinase and AMP-activated protein kinase. Tanida M; Yamamoto N; Morgan DA; Kurata Y; Shibamoto T; Rahmouni K J Neurosci; 2015 Jan; 35(2):474-84. PubMed ID: 25589743 [TBL] [Abstract][Full Text] [Related]
11. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle. Suwa M; Nakano H; Radak Z; Kumagai S Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304 [TBL] [Abstract][Full Text] [Related]
12. 5-aminoimidazole-4-carboxamide-1-beta-ribofuranoside (AICAR) prevents nuclear translocation of constitutive androstane receptor by AMP-activated protein kinase (AMPK) independent manner. Kanno Y; Inoue Y; Inouye Y J Toxicol Sci; 2010 Aug; 35(4):571-6. PubMed ID: 20686344 [TBL] [Abstract][Full Text] [Related]
13. Effects of intragastric injection of glutamate on efferent sympathetic nerve activity in rats. Tanida M; Satomi J Neurosci Lett; 2011 Mar; 491(3):211-5. PubMed ID: 21256926 [TBL] [Abstract][Full Text] [Related]